Edap Tms SA
focalone.comWhat Do They Do?
Sells robotic focused-ultrasound devices to hospitals and clinics for urologists treating prostate cancer.
10-K for FY2025, filed Mar 25, 2026EDAP TMS S.A. (“EDAP,” the “Company,” “we,” “us,” or “our”) is a medical technology company focused on the development, manufacturing…View ↗
Our technologies are primarily used in urology, with a current focus on the treatment of prostate cancer. We are conducting clinical…View ↗
Our flagship product, the Focal One i Robotic HIFU System (the “Focal One i System”), allows urologists to ablate targeted prostate tissue…View ↗
Our customers are located worldwide and include academic, public, and private hospitals as well as clinics. We primarily market to…View ↗
How Do They Make Money?
Hospitals and clinics buy devices and consumables, generally invoiced on delivery. They pay per treatment or lease Focal One over time; spare parts are invoiced on delivery, while maintenance is paid by subscription or when service is performed.
10-K for FY2025, filed Mar 25, 2026Our customers are located worldwide and include academic, public, and private hospitals as well as clinics. We primarily market to…View ↗
- Sales of goods (devices and consumables), where invoicing generally takes place upon delivery. Consumables revenues included in sales…View ↗
- Revenue-per-Procedures (“RPP”) and leases: they comprise (i) revenues on a per treatment basis which are invoiced after each treatment…View ↗
- Sales of spare parts and services (maintenance, upgrades, mobility and others). Spare parts are invoiced when delivered. Regarding…View ↗
-
10-K for FY2025, filed Mar 25, 2026
FY2025 revenue by product or service ↗
$70.5M
-
10-K for FY2025, filed Mar 25, 2026
$70.5M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Goods
Sold outright
10-K for FY2025, filed Mar 25, 2026 |
69%
FY2022: 70%
|
Goods, FY2025
$48.9M Sources
|
Sold outright |
|
RPPs & leases
|
15%
FY2022: 10%
|
RPPs & leases, FY2025
$10.3M Sources
|
|
|
Spare parts and services
Mix
10-K for FY2025, filed Mar 25, 2026 |
16%
FY2022: 20%
|
Spare parts and services, FY2025
$11.3M Sources
|
Mix |
Who Are Their Customers?
Hospitals and clinics buy through the company's direct sales channels in key markets and through distributors and agents elsewhere; it markets mainly to urologists, with gynecologists targeted in select markets.
10-K for FY2025, filed Mar 25, 2026
Do Revenues Turn Into Profits?
No. It lost $29.2M in FY2025.
10-K for FY2025, filed Mar 25, 2026
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 14, 2026
−$14.5MView ↗
- ▲ +126% (Loss)
- vs −$6.4M in Q2 FY2025
10-Q for Q2 FY2026, filed Aug 14, 2026
Open tableView ↗
-
Aug 11, 2026
Plans exit of ESWL and Distribution segments
The segments were classified as held for sale and discontinued operations after the company determined the planned exit would significantly affect its operations and results.
Sources
8-K, filed Aug 11, 2026
During the second quarter of 2026, the Extracorporeal Shock Wave Lithotripsy (ESWL) and Distribution segments met the criteria to be…View ↗
Greater focus on HIFU
The older report described ESWL and third-party distribution as active divisions supporting the HIFU strategy. The latest report says the company has realigned to focus exclusively on HIFU applications, while still marketing and supporting legacy lines.
20-F for FY2022, filed Apr 7, 2023 10-K for FY2025, filed Mar 25, 2026
Who Do They Compete With?
Competes with Sonablate, Profound Medical, Insightec, and Haifu
10-K for FY2025, filed Mar 25, 2026Sonablate Corporation, a U.S. company that markets the Sonablate® system for ablation of prostatic tissue;View ↗
Loading...
